CONNECT WITH US
Tech

Tech

US researchers build $450 bioprinter that prints living structures over 100 layers tall

Interesting Engineering – Innovation logo

Published on

Add as a preferred source on Google
US researchers build $450 bioprinter that prints living structures over 100 layers tall

Researchers at the University of Rochester and Cornell University have turned a standard 3D printer into a $450 bioprinter capable of building living structures more than 100 layers tall.

The machine can also print shapes with hollow cavities, giving scientists more control over the geometry of materials that contain living cells.

The researchers set out to address two problems with bioprinting: commercial machines can cost upward of $100,000, and the soft structures they produce can collapse before they set.

A conventional 3D printer deposits molten plastic layer by layer. The team replaced the plastic filament extruder with a syringe pump that dispenses bio-ink, a mixture of living cells and a polymer solution. The ink sets into a gel after printing, holding the cells within the finished shape.

The syringe can also pull back the ink. That gives the printer more control over where the material stops flowing, reducing the ooze that can blur the edges of a print.

“We aim to create DIY bioprinters using inexpensive, easily obtainable parts, so that they are affordable and easy for other scientists to make in their own labs as well,” said Anne Meyer, a University of Rochester biology professor.

Earlier DIY bioprinters could produce structures fewer than 20 layers tall. To build taller prints, the team deposited the bio-ink into a soft support gel, known as a slurry.

The surrounding gel holds each layer in place while it sets, allowing the printer to keep adding material without the lower layers collapsing.

The same support makes it possible to leave hollow spaces inside a print.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.